M MtoZ Biolabs
Home > Support > Resources > What Are the Quantitative Methods for Proteomics?

Quantitative methods for proteomics are liquid chromatography-tandem mass spectrometry (LC-MS/MS) strategies that turn peptide signals into relative protein comparisons, or into peptide amounts when a matched stable isotope-labeled internal standard (SIS) is present (Bantscheff et al. 2012). The shared principle is not a dye-binding total-protein assay. Digests are measured as peptides, a declared quantitative trace is extracted, and the same protein is compared across samples under stated identification and error-rate rules.

A method name is incomplete until three axes are stated together: labeling chemistry, acquisition mode, and claim type. Unlabeled work is not the same decision as data-independent acquisition (DIA). Isobaric tagging is not the same decision as a closed targeted list. In MtoZ Biolabs offerings, unlabeled digests are commonly acquired as data-dependent acquisition (DDA) label-free or as DIA, tandem mass tag (TMT) workflows are typically acquired as DDA to read reporters, and named proteins are typically followed by parallel reaction monitoring (PRM), with multiple reaction monitoring (MRM) when a scheduled triple-quadrupole panel already exists.

What Counts as a Quantitative Proteomics Method

A quantitative proteomics method must produce a protein- or peptide-by-sample value that can support a predefined contrast or a calibrated amount. Identification alone is not quantification. Spectral counting can rank how often a protein was sampled. It is a weak substitute for intensity-based relative matrices when fold-change statistics are required.

Relative quantification compares the same protein across samples inside one study. Absolute quantification reports mass or molar units only when a matched SIS and a calibration rule are declared (Gerber et al. 2003). Intensity-based copy-number estimates from unlabeled matrices are planning tools. They are not SIS-calibrated amounts.

Bulk Bradford, bicinchoninic acid (BCA), Lowry, and 280 nm assays measure total protein load. They help match input before digestion. They are outside the definition of quantitative proteomics methods used here. Researchers who need how to choose among LC-MS routes after the definition is clear can refer to Protein Quantification Method.

How Major Method Families Create a Quantitative Signal

Unlabeled methods leave each digest on its own injection. After identification or DIA extraction, relative abundance comes from MS1 peak areas or from fragment chromatograms recovered from scheduled isolation windows (Cox et al. 2014; Gillet et al. 2012). Missing values and cross-run alignment are part of the method, not optional extras.

Metabolic labeling, such as stable isotope labeling by amino acids in cell culture (SILAC), incorporates heavy amino acids during protein synthesis. Light and heavy forms of the same peptide are distinguished at the precursor level after mixing. The principle fits cells that can be grown on labeled media. Tissue and biofluid projects usually cannot use that step.

Isobaric chemical tags such as TMT attach channel-specific reagents so mixed peptides share one precursor mass and release distinct reporter ions after fragmentation (Thompson et al. 2003). Relative abundance is read from reporters, not from the intact MS1 peak area. Other isobaric or amine-methylation chemistries follow the same idea of early mixing with different channel bookkeeping. Multiplexed isobaric projects are typically evaluated as TMT when that route is the available isobaric offering.

Targeted methods schedule a closed peptide list. MRM/SRM monitors predefined precursor-fragment transitions. PRM records a high-resolution fragment spectrum for each scheduled precursor (Lange et al. 2008; Peterson et al. 2012). Relative targeted peak areas become amounts only when a matched SIS is included. Researchers can refer to Principle of Targeted Proteomics for the inclusion-list isolation principle, and to Absolute Protein Quantification for SIS-supported amount claims.

A quantitative proteomics method is defined by the signal it extracts and the claim that signal is allowed to support.

Four quantitative proteomics method families: unlabeled intensity, metabolic isotope pairs, isobaric reporters, and targeted fragment traces

Figure 1. Quantitative proteomics methods differ by how peptide signals are created and read; relative comparison is the default claim unless a matched SIS is present.

Parameters That Belong in the Method Definition

Every quantitative method definition should name the quantitative object: MS1 area, DIA fragment trace, reporter ion, or targeted extracted peak. It should name peptide and protein false discovery rate (FDR) rules, unique-peptide inference, and the replicate structure that the contrast will use.

Design parameters decide whether the definition can be applied. Open enrollment favors separate unlabeled injections. A freezable multi-group set can support isobaric mixing. A closed name list supports targeting. Sample chemistry decides whether amines can be tagged or whether metabolic labeling is even possible.

Acquisition parameters must match the chemistry. Reporter methods need spectra in which reporters are measured. DIA needs a declared window scheme. Targeted methods need a locked schedule. Mixing incompatible quantitative objects in one statistical model without a bridge creates contrasts the data cannot defend.

Claim parameters include normalization assumptions, missing-value rules, and, for amount claims, SIS identity and spike point. A method title without those items is a label, not a methods record.

Limits Built into the Definition of Quantitative Methods

Quantitative proteomics methods report peptide-derived values. One peptide does not automatically represent every isoform or modified form of a protein. Shared peptides report protein groups.

Relative methods do not become absolute by printing more digits. Isobaric reporter ratios can compress when co-isolation mixes channels. Unlabeled matrices carry missingness that is often abundance-dependent. Targeted methods do not inventory proteins outside the inclusion list.

Instrument platform names, kit channel counts, and pathway enrichment are not part of the core definition. They are implementation and interpretation choices that sit on top of a declared quantitative signal and claim.

Mapping a Project Question onto a Method Family

The useful test is whether the protein list is open, whether samples can be mixed or must stay separate, and whether the unit is a ratio or an amount.

Project question

Method family that often fits

Definitional limit to keep

Open relative discovery, files may still be added

Unlabeled DDA or DIA intensity

Cross-run alignment and missingness remain

Open relative discovery, set can be mixed now

Isobaric reporter plex such as TMT

Later files are not extra channels

Relative comparison in labeled cell culture

Metabolic isotope pairs such as SILAC

Not a default for tissue or plasma

Remeasure named peptides

Targeted PRM or MRM

Off-list proteins stay unseen

Mass or molar unit for named peptides

Targeted method plus matched SIS

Peptide amount is not protein copy number by default

Total protein load matching only

Bulk dye or A280 assay

Outside quantitative proteomics as defined here

Mapping a research question to unlabeled, targeted, or non-proteomics bulk assays

Figure 2. Map the project question to a method family from list status and claim unit; bulk load assays sit outside this definition.

Unlabeled discovery more often fits open enrollment. Isobaric plexes more often fit freezable multi-group sets. Targeted methods more often fit after names freeze. Exceptions exist when a tiny validated panel never needed discovery, or when a short closed cohort must share one injection to limit run-order drift.

Researchers who already have sample type, group design, and a requested claim can also review the MtoZ Biolabs Quantitative Proteomics Service for project-specific method planning.

Frequently Asked Questions

1. Are label-free and DIA two names for the same quantitative method?

No. Label-free names the absence of isotopic or isobaric sample tags. DIA names a scheduled-window acquisition mode. Unlabeled digests are often acquired as DIA, and the two decisions stay separate.

2. Does every quantitative proteomics method report absolute concentration?

No. Most discovery methods report relative ratios. Absolute reporting starts when a matched SIS and a calibration rule are present for the measured peptide.

3. Is identification depth the same as quantification quality?

No. A long protein list can still contain features that fail quantitative filters. The method definition requires a usable quantitative trace, not only a peptide-spectrum match.

4. Can TMT reporter height rank different proteins as copy numbers?

No. Reporters support same-peptide relative comparison across channels. Cross-protein ranking from reporter height is outside that claim.

5. When does a quantitative method stop being discovery and become targeted?

When the peptide list is closed and only scheduled precursors are isolated for quantification. Discovery keeps an open inventory. Targeting remeasures a locked list.

MtoZ Biolabs can provide quantitative proteomics methods across unlabeled DDA or DIA discovery, TMT relative plexes, and targeted PRM or MRM follow-up when sample type, study design, and the intended claim are available.

If further evaluation of labeling versus acquisition, relative versus SIS-supported amount, or whether a bulk load assay is sufficient is needed, project details can be submitted for a feasibility review.

Reference

  1. M. Bantscheff, S. Lemeer, M.M. Savitski, B. Kuster (2012). Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal. Bioanal. Chem., 404, 939-965. https://doi.org/10.1007/s00216-012-6203-4
  2. J. Cox, M.Y. Hein, C.A. Luber, I. Paron, M. Mann (2014). Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics, 13, 2513-2526. https://doi.org/10.1074/mcp.M113.031031
  3. S.A. Gerber, J. Rush, O. Stemman, M.W. Kirschner, S.P. Gygi (2003). Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.S.A., 100, 6940-6945. https://doi.org/10.1073/pnas.0832254100
  4. L.C. Gillet, P. Navarro, S. Tate, H. Rost, N. Selevsek, L. Reiter, R. Bonner, R. Aebersold (2012). Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics, 11, O111.016717. https://doi.org/10.1074/mcp.O111.016717
  5. V. Lange, P. Picotti, B. Domon, R. Aebersold (2008). Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol., 4, 222. https://doi.org/10.1038/msb.2008.61
  6. A.C. Peterson, J.D. Russell, D.J. Bailey, M.S. Westphall, J.J. Coon (2012). Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics, 11, 1475-1488. https://doi.org/10.1074/mcp.O111.013698
  7. A. Thompson, J. Schafer, K. Kuhn, S. Kienle, J. Schwarz, G. Schmidt, T. Neumann, R. Johnstone, A.K. Mohammed, C. Hamon (2003). Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem., 75, 1895-1904. https://doi.org/10.1021/ac0262560
 

How to Order

How to Order
Request a Quote

Request a Project Quote

Please complete the required fields below. We will review your information and respond with a tailored recommendation.

Project inquiry

Fields marked with * are required for quote review.

Secure inquiry · No obligation
Required Information

Your information will be used only to respond to your inquiry.

Submit Inquiry